Free triiodothyronine was assayed in serum of 1050 euthyroid children with the Amerlex-MAB method. We studied 50 samples for each year of age, from <1 to 20, and no child had more than one sample taken. A gradient of values was observed, increasing by 31% from 5.04 pmol/L as the mean of 20-year-old patients to 6.59 pmol/L in the serum of children younger than 1 year. For practical reasons the lower normal limit was proposed to remain at 3.4 pmol/L for all patients; the higher limit can be set at 8.3 (0 to 3 years), 7.8 (4 to 7 years), 7.1 (8 to 11 years), 6.8 (12 to 15 years), and 6.7 (16 to 19 years). Preferably, the regression line of the mean ؉ 2 SD can be used, resulting in a high normal limit of 8.
Hyperthyroidism is unusual in children. It has been calculated to occur as Graves disease in up to 0.2% and 0.4% of the pediatric and adolescent population, respectively [1] . The attention of endocrinologists has recently been drawn to this subject [2] . The hallmark of hyperthyroidism is a low thyrotropin (TSH) value. 1 However, a low TSH value can occur in a host of other situations. The next most important assay in the differential diagnosis is a triiodothyronine (T 3 ) assay: T 3 increases earlier than thyroxine [3] . Like all other patients, these children deserve to have dependable reference ranges for the hormones they will have assayed in their serum.
Although recommended in nearly all kit inserts, the setting of normal ranges by individual laboratories is often very difficult, and more so for children. Free T 3 (fT 3 ) presents a special problem. The direct assay of free thyroid hormones is the subject of multiple criticisms [4, 5] . Nevertheless, these assays have imposed themselves in multiple laboratories for reasons of cost and convenience. Normal ranges of fT 3 in children are hard to come by, as very few references are available [1, 6, 7] . When introduced in our laboratory as the Amerlex-MAB fT 3 assay, I was asked to set them.
Patients and Methods methods
FT 3 was assayed exactly as prescribed by the manufacturers (Amerlex MAB; Ortho Clinical Diagnostics, Amersham, UK; sold in Belgium by Orange, Brussels, Belgium). Temperatures were kept constant within 1°C, at 22°C. Pipettes are checked every 8 weeks for precision and repeatability. Interassay variance was controlled by the inclusion of aliquots of Lyphocheck levels II (lot 93002) and III (lot 93003). Level II had a mean of 8.06 pmol/L; the CV was kept under 6.5% throughout the 6-month period. Level III had a mean of 25.9 pmol/L with a CV under 8.0%. Control sample sets were run at the beginning of each daily assay, after the 50th patient tube, and at the end if Ͼ25 tubes were present after the last control set. All assays were done singly. The tubes were counted in a Canberra Packard (Zellik, Belgium) Riastar 5420 (Packard Instruments, Meriden, CT; sold in Belgium by Canberra Packard), with a spline interpolation to plot the results on the calibration curve. Descriptive statistics were calculated with the package included in Quattro Pro (version 6.01 for Windows; Novell, Orem, UT). With the same package, the significance of differences between variances of the groups were calculated with the F-test and the significance of differences between the means of the groups with the t-test for groups with unequal variances. Tests for normality were done according to Snedecor and Cochran [8] . The regression analysis was calculated with the programs of Microsoft Excel for Windows95 (Microsoft, Redmond, WA). patients All samples used for this investigation were drawn with the purpose of reaching a clinical diagnosis. After sufficient serum had been set aside for all requested analyses, the remainder of the serum, rather than being thrown directly to the waste, was used for this investigation, which is kept totally anonymous. Therefore, our procedures are in accordance with the Helsinki Declaration of 1975, as revised in 1983.
On all serum samples entering the laboratory, fT 3 was assayed if the patient was Ͻ21 years old, all requested tests already had the necessary volume taken off, the patient had not yet a sample in the cohort, and no thyroid test was requested on any of this patient's samples in the database of the laboratory. This precaution, taken together with the low prevalence of the rarer thyroid diseases with a normal TSH, makes it extremely unlikely that children with such a disorder would be included in this study. A TSH test as routine screening did not cause an exclusion of the serum, provided the result proved normal. At the outset I decided to try to have 50 assays for each year of age and to stop after 6 months. All assays were done between August 16, 1995 and February 5, 1996. Four parameters were kept for each serum: age, fT 3 result, code number for the presumptive diagnosis, and identification number of the sample. The diagnosis was presumed on the basis of either, when available, the reason for the request given by the practicing physician or the type of assays requested and the results thereof. Diagnoses were then grouped in classes. When the presumed diagnosis suggested a possible thyroid involvement, TSH was assayed and the sample included only if this TSH result was normal.
Results
The mean fT 3 value of the 20-year-old patients is 5.04 pmol/L. The 50 children of Ͻ1 year have a mean fT 3 of 6.59 pmol/L. A gradient decreasing from young to older can be observed in Fig. 1 . Deviations from the gaussian distribution are present in various amounts within the different groups; none reaches statistical significance (data not shown). To have dependable reference populations, results are grouped in five classes of 4 years of age each (Table 1) , with the 20-year-old patients present as a check on the adult reference range. Thus each class has 200 samples. The distribution within the classes is normal for all, as shown in Table 1 , except for the skewness of the 4 -7-year-old class. This is due to the presence in this class of two of three values from the 1050 being between Ϫ3 and Ϫ4 SD. Deleting those two values gives a perfectly gaussian distribution. To exclude the possibility of striking changes in the first few weeks of life, the results of the children younger than 1 year are plotted on a separate graph ( Fig. 2 ). Among the five classes mentioned, the significance of the differences between the variances was calculated with the F-test. Because several of the differences in variances are highly significant (P between 0.15 and 10 Ϫ9 ), the comparisons between the means of the classes were done with t-tests for groups with unequal variances. Most of the differences between the means of the classes are highly significant (P between the nearest classes 0.035 to Ͻ10 Ϫ7 ). The regression analysis across the 21 groups shows a highly significant correlation (P Ͻ10 Ϫ50 ) between age and fT 3 value, although with a large variance within the groups, which results in a correlation factor R of only 0.44, R 2 ϭ 0.19. The details of this calculation are in Table 2 . To use all the results in the calculation of the high normal limit, a second regression line is calculated, this one with the mean ϩ 2 SD values of the classes. The resulting equation is x ϭ Ϫ0.098y ϩ 8.29. Here again, x is fT 3 in pmol/L and y is the age in years. There are 23 values higher than the mean ϩ2 SD regression line, almost exactly 2.5%,which confirms the gaussian distribution of the population. Three of those values are between 3 and 4 SD above the mean. One is a 14-year-old child who has Still disease (juvenile arthritis), a second is a 17-year-old athlete after a training session, and the third is an 18-year-old girl with an acute infection. Although low fT 3 values are of little diagnostic use, there are also three values between 3 and 4 SD under the mean. They are from a 4-year-old girl with negative results for a radioallergosorbent test (RAST) for pollen, from a 6-yearold boy with an acute mycoplasma infection, and from a 17-year-old girl with a growth problem.
The most often quoted possible diagnosis is infection or serological check after an infection (378 samples). The next most frequent diagnosis is allergy (253 samples): In the younger children the serum was then sent for RAST for milk allergens; in older children it was for RAST for pollen, epithelia of domestic animals, or house dust mite. Other frequent reasons for sending a sample were anemia (91), serologic control before or after a vaccination (81), checks on athletes (48 older children), and preoperative controls-generally ear, nose, and throat (46). There were also samples for investigation of acne (26), arthritis (24), pubertal anomalies (20), therapeutic drug monitoring (13), and renal disease (13). This leaves 57 samples sent for other reasons.
Discussion
The results presented here are most probably representative for a normal pediatric population. There is some discrepancy with the results of Butler et al. [6, 7] with the older version of the Amerlex fT 3 . Their conclusion that fT 3 is higher in children of 7 to 12 years than in younger children seems to be due to too small a population. Furthermore, the Amerlex-MAB method gives lower fT 3 values than the older Amerlex-M. Our reference values for fT 3 , as the 2.5 to 97.5 percentiles of Ͼ3000 patients with a normal TSH, children included, are 3.4 to 7.2 pmol/L, identical to the normal reference interval stated on the kit insert. When the children are excluded we obtain the 97.5 percentile at 6.14 pmol/L, very near to the value obtained by Piketty et al. with 98 healthy blood donors: 6.3 pmol/L [9] .
Comparing different methods of fT 3 determinations is a very tricky business, especially in patients with nonthyroidal illness and those treated with amiodarone [10] . Fortunately, none of the children in our series was treated with amiodarone. Nonthyroidal illness to the point of interfering with thyroid metabolism is certainly uncommon in children. However, I cannot exclude that some of the few outliers to the lower values were due to that phenomenon, especially the 6-year-old boy with an acute mycoplasma infection. Deleting them ensures a gaussian distribution, so acceptance of the regression line at ϩ2 SD as the upper limit of normal seems warranted.
Nevertheless, it was a bit surprising to discover that the mean fT 3 of the 20-year-olds in our series (5.04 pmol/L) is nearer to the equilibrium dialysis mean (5.15 pmol/L) than to the Amerlex-MAB (5.57 pmol/L) mean of the controls in Sapin et al.'s paper [10] . But then, we are comparing a group of 50 with a group of 30. With such low numbers the difference between the means is not significant. Therefore, since the control group with the equilibrium dialysis assay has its values within the normal range of the Amerlex-MAB, we conclude that there is no difference in fT 3 results between Amerlex-MAB and the equilibrium dialysis in controls, i.e., when the structure of the serum is normal. When discussing the normal ranges for fT 3 it is important to realize that, in the assessment of a patient, fT 3 is never a parameter on its own. It always must be interpreted in conjunction with the TSH result and, of course, in conjunction with the other information the clinician has on the patient. I present here reference values for fT 3 in a pediatric population of 1050 euthyroid children determined by the Amerlex-MAB kit, evenly distributed over 0 to 20 years of age.The group of 50 children Ͻ1 year has a mean fT 3 of 6.59 pmol/L with a SD of 1.02 and a SEM of 0.128 pmol/L. There is no steep increase towards the very early weeks of life. The group of 50 20-year-olds has a mean of 5.04 pmol/L with a SD of 0.69 and a SEM of 0.097 pmol/L. Thus the mean fT 3 of the children Ͻ1 year old is at 2 SD and 16 SE, or 31% above the mean of the 20-year-olds (P Ͻ10 Ϫ15 ). There is a continuous rising gradient from older to younger. It remains true that most children have fT 3 values within the normal ranges for adults. Nevertheless, the interpretation of slightly increased values should be made easier, taking into account the results of this investigation. Thus the lower limit for normal ranges would be kept at 3.4 pmol/L for all ages. For the higher limit, preference can be given to 8.3 pmol/L (0 to 3 years), 7.8 (4 to 7 years), 7.1 (8 to 11 years), 6.8 (12 to 15 years), and 6.7 (12 to 19 years). This division in groups of 4 years of age is arbitrary. The best way to assess a specific value is to look at Fig. 1 for comparison. As it is usually not feasible for the clinical laboratory to print it on the results proto-cols, it is possible to follow the lead of Oesterling et al., dividing their huge group of prostate-specific antigen in decades of age of the men whose serum was analyzed [11] . However, with the regression line of the mean ϩ 2 SD, the higher limit for each year can be calculated as 6.3 pmol/L at 20 years, adding 0.1 pmol/L for each year less, to 8.3 at Ͻ1 year. This is obviously a more precise method.
Taking into account the criticisms leveled at the direct free hormone assays by endocrinologists [4, 5] , it is unlikely that the physiological relevance of this observed trend in fT 3 concentration related to age will ever be unraveled.
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